BIO-TECHNE Corp (TECH) Profit Breakdown
- 2026-06-30: Protein Sciences $655.78M; Diagnostics and Spatial Biology $185.81M.
- 2025-06-30: Protein Sciences $658.02M; Diagnostics and Spatial Biology $198.32M.
- 2024-06-30: Protein Sciences $628.92M; Diagnostics and Spatial Biology $191.43M.
Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.
- Available history
- 2009-06-30 to 2026-06-30
- Data captured
Profit by product
Gross margin: each year (12 month)
| Fiscal year end | Protein Sciences | Diagnostics and Spatial Biology |
|---|---|---|
| 2026-06-30 | $655.78M derived | $185.81M derived |
| 2025-06-30 | $658.02M derived | $198.32M derived |
| 2024-06-30 | $628.92M derived | $191.43M derived |
Operating income: each year (12 month)
| Fiscal year end | Protein Sciences | Diagnostics and Spatial Biology |
|---|---|---|
| 2026-06-30 | $359.40M | $37.70M |
| 2025-06-30 | $370.35M | $21.32M |
| 2024-06-30 | $354.77M | $24.55M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |